Skip to main content

UBS Group AG

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in CTMX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$13,006,346
-$1,658,382 QoQ
Shares Held
3,468,359
+11.2% QoQ
Ownership
1.59%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 178 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CTMX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. CTMX ranks #100 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CTMX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,006,346 3,468,359
2026-03-31 $14,664,728 3,120,155
2025-12-31 $1,579,347 370,739
2025-09-30 $96,235 30,168
2025-06-30 $926,239 408,035
2025-03-31 $474,957 746,788
2024-12-31 $523,812 508,556
2024-09-30 $81,578 69,135
2024-06-30 $85,848 70,368
2024-03-31 $44,674 20,493
2023-12-31 $31,072 20,047
2023-09-30 $24,126 18,703
2023-06-30 $36,876 21,440
2023-03-31 $40,456 26,793
2022-12-31 $73,279 45,800
2022-09-30 $25,799 17,793
2022-06-30 $7,700 4,208
2022-03-31 $4,560 1,708
2021-12-31 $608,282 140,481
2021-09-30 $800,009 157,173
2021-06-30 $159,838 25,251
2021-03-31 $629,685 81,460
2020-12-31 $9,222 1,408
2020-09-30 $7,980 1,200
2020-06-30 $9,996 1,200
2020-03-31 $173,778 22,657